Gerald Perret

Gerald Perret, PhD, currently serves as the Global Programs Director at Genethon, a leading organization at the forefront of advanced therapeutics, including gene and cell therapies. In this strategic role, he oversees the management and coordination of innovative programs that aim to develop transformative biopharmaceutical solutions for rare and genetic diseases. His responsibilities encompass the strategic and centralized oversight of complex R&D initiatives, ensuring seamless integration across various stages of development—from early innovation to clinical and regulatory milestones. Gerald’s expertise in pharmaceutical biotechnology, combined with his comprehensive understanding of GMP, BPF, and quality assurance standards, positions him as a key driver in advancing Genethon’s mission to translate cutting-edge science into viable therapies.

Throughout his over 25-year career in the pharmaceutical industry, Gerald has demonstrated a profound ability to navigate the intricacies of biologics development, including regulatory compliance, clinical development, and manufacturing processes such as cell culture and CMC. His leadership extends to managing alliances and strategic partnerships, where he orchestrates joint committees and international consortiums to foster collaboration and accelerate therapeutic innovation. As Head of the Programs Management Team, he leads a multidisciplinary team of global project managers, CMC specialists, and portfolio managers, ensuring alignment with organizational goals and industry standards.

Gerald’s strategic vision is complemented by his assertiveness and integrity, which underpin his approach to managing complex projects and stakeholder relationships. His expertise in life sciences, GMP, change control, and biopharmaceutical development makes him a pivotal figure in shaping the future of gene and cell therapies, ultimately contributing to the advancement of personalized medicine and transformative healthcare solutions.